Item 2.02 Results of Operations and Financial Condition.
On July 26, 2022, USANA Health Sciences, Inc. (the “Company” or “USANA”) issued
a press release announcing its financial results for the second quarter ended
July 2, 2022. The release also announced that the Company will post a document
titled “Management Commentary” on the Company’s website and that executives of
the Company will hold a conference call with investors, to be broadcast over the
World Wide Web and by telephone and provided access information, date and time
for the conference call. The Company noted that the call will consist of brief
remarks by the Company’s management team, before moving directly into questions
and answers. A copy of the press release, and the Management Commentary, are
furnished herewith as Exhibits to this Current Report on Form 8-K and are
incorporated herein by reference. These documents will be posted on the
Company’s corporate website, http://www.usana.com.
The information in this Current Report is being furnished and shall not be
deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of that Section. The
information in this Current Report shall not be incorporated by reference into
any registration statement or other document pursuant to the Securities Act of
1933, as amended. The furnishing of the information in this Current Report is
not intended to, and does not, constitute a representation that such furnishing
is required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly
Item 7.01 Regulation FD Disclosure
The information disclosed above under Item 2.02, as well as the exhibits
attached under Item 9.01 below are incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by USANA Health Sciences, Inc. dated July 26, 2022 (furnished herewith). 99.2 Management Commentary provided by USANA Health Sciences, Inc. dated July 26, 2022 (furnished herewith).
© Edgar Online, source Glimpses